Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00339248 | Markers for Breast Cancer | completed | — | 2,632 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2009 | clinicaltrials |
| NCT00043394 | CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer | completed | Phase 2 | 16 | PfizerINDUSTRY | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00200824 |
| Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health |
| completed |
| Phase 2 |
| — |
| National Center for Complementary and Integrative Health (NCCIH)NIH |
| 1 |
| Mar 12, 2009 |
| clinicaltrials |
| NCT00859560 | Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg | completed | — | 2,205 | AstraZenecaINDUSTRY | 0 | Mar 11, 2009 | clinicaltrials |
| NCT00623519 | Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole | completed | — | 165 | AstraZenecaINDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00587925 | Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer | completed | N/A | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00531973 | A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging(LITE) | unknown | Phase 4 | 80 | Catholic University, ItalyOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00003016 | Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer | unknown | Phase 3 | 20,000 | University of OxfordOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | unknown | Phase 2 | — | Institute of Cancer Research, United KingdomOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00077168 | Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | unknown | Phase 2 | 2,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00309920 | Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer | unknown | N/A | 1,234 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00299117 | Brief Smoking Intervention for Women Undergoing Breast Cancer Surgery | completed | N/A | 130 | Herlev HospitalOTHER | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00743353 | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5(K5) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00276211 | Diffusion Weighted MRI for Lymphnodes in the Axilla | completed | — | 10 | Copenhagen University Hospital at HerlevOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00637364 | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain(HIFU Pancreas) | suspended | Phase 1 / Phase 2 | 5 | CMED HIFU Development CorporationINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00364195 | Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer | completed | Phase 2 | 33 | YM BioSciencesINDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00809484 | Arimidex Bone Mass Index and Oral Bisphosphonates(ARBI) | completed | — | 220 | Hellenic Breast Surgeons SocietyOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00548392 | Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement | completed | — | 25 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00815555 | CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients | unknown | — | 500 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Dec 30, 2008 | clinicaltrials |
| NCT00810706 | Adjuvant Post-Tamoxifen Exemestane Trial(ATENA) | terminated | Phase 3 | 448 | Hellenic Breast Surgeons SocietyOTHER | 1 | Dec 18, 2008 | clinicaltrials |
| NCT00808522 | Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women | unknown | Phase 3 | 84 | New York Presbyterian HospitalOTHER | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00378313 | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | completed | Phase 2 | 76 | NSABP Foundation IncNETWORK | 1 | Nov 26, 2008 | clinicaltrials |
| NCT00188591 | Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study | completed | — | 20 | University Health Network, TorontoOTHER | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00198250 | Venlafaxine for Hot Flashes After Breast Cancer | completed | Phase 2 | 75 | Indiana UniversityOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00237354 | PV-10 Chemoablation of Recurrent Breast Carcinoma | completed | Phase 1 | 15 | Provectus PharmaceuticalsINDUSTRY | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00777530 | Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects | completed | Phase 1 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Oct 23, 2008 | clinicaltrials |
| NCT00764972 | Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 36 | McGill UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00303615 | Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer | terminated | Phase 2 | 5 | Legacy Health SystemOTHER | 1 | Oct 20, 2008 | clinicaltrials |
| NCT00156260 | Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage | terminated | — | 88 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 8, 2008 | clinicaltrials |
| NCT00669747 | Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | unknown | Phase 2 | 45 | Windy Hill Medical, Inc.INDUSTRY | 1 | Oct 2, 2008 | clinicaltrials |
| NCT00228930 | Tamoxifen Pharmacogenetics and Clinical Effects | completed | — | 297 | National Institute of General Medical Sciences (NIGMS)NIH | 1 | Sep 25, 2008 | clinicaltrials |
| NCT00228956 | Aromatase Inhibitor Clinical Trial | unknown | — | 500 | National Institute of General Medical Sciences (NIGMS)NIH | 1 | Sep 25, 2008 | clinicaltrials |
| NCT00380835 | Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer | withdrawn | Phase 2 | 66 | Celgene CorporationINDUSTRY | 1 | Sep 23, 2008 | clinicaltrials |
| NCT00328432 | A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy | completed | Phase 1 | 100 | University of KansasOTHER | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00291109 | An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg | completed | — | 40 | University of KansasOTHER | 1 | Sep 16, 2008 | clinicaltrials |
| NCT00291122 | An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer | completed | — | 100 | University of KansasOTHER | 1 | Sep 16, 2008 | clinicaltrials |
| NCT00594282 | Use of a Radiolucent Pad to Reduce Mammography Among African Americans | completed | N/A | 300 | University of KansasOTHER | 1 | Sep 12, 2008 | clinicaltrials |
| NCT00120029 | Peer Counseling for Weight Loss | unknown | N/A | 100 | Wayne State UniversityOTHER | 1 | Sep 5, 2008 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00115414 | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Aug 1, 2008 | clinicaltrials |
| NCT00717951 | A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer | unknown | Phase 2 | 120 | Academy Military Medical Science, ChinaINDUSTRY | 0 | Jul 25, 2008 | clinicaltrials |
| NCT00006120 | Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00025688 | Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer | unknown | Phase 3 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00428896 | A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer | completed | Phase 2 | 24 | University Hospital of CreteOTHER | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00162812 | Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin(TOP) | terminated | Phase 2 | 338 | Jules Bordet InstituteOTHER | 1 | Jul 18, 2008 | clinicaltrials |
| NCT00217815 | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 20 | NeuTec PharmaINDUSTRY | 2 | Jul 15, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00387062 | Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment | completed | Phase 1 | 50 | Posit Science CorporationINDUSTRY | 1 | Jun 24, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Mar 13, 2009source: clinicaltrials